James is a Reader in Genomic Medicine at Imperial College, and a group head within the Cardiovascular Genetics & Genomics Unit. He practices clinically as a Consultant Cardiologist at Royal Brompton & Harefield Hospitals, where he is research lead for Inherited Cardiac Conditions. He also holds a visiting scientist position at the Broad Insitute of MIT & Harvard in Boston, MA.
Paul Barton is Honorary Senior Research Fellow at Imperial College and Genetics Research Manager at the Royal Brompton Hospital. His research interests include gene-environment interaction, noncoding RNA, and enhancing international collaboration, currently through research partners based in Florence, Madrid and the Aswan Heart Centre in Egypt.
Rachel is a molecular biologist with an interest in the genetics of inherited cardiac conditions. She oversees the wet-lab based projects in the Cardiovascular Genetics and Genomics Group at the Royal Brompton and the Heart Hive - a web based portal to connect people with cardiomyopathy with research opportunities.
Maria is a Cardiology Specialist Registrar and a PhD Clinical Research Fellow. Her research focus is in investigating utility of diffusion tensor cardiovascular magnetic resonance as a novel non-invasive method evaluating cardiac muscle microstructure. Maria's specialist training and research interests are in cardiovascular imaging and inherited cardiomyopathy.
Catherine EnrightCatherine is the Cardiovascular Genetics & Genomics Research Group Manager, responsible for the day to day operation and administration of the Group including finance, grants and HR and contributes to strategic planning. Catherine previously worked for the British Heart Foundation then joined Imperial College to manage the Cardiac Medicine BHF Chair Department. She moved to central NHLI Section Administration, supporting cardiovascular groups at St Mary’s and South Kensington campuses before returning to Royal Brompton. She joined the Group in 2019. firstname.lastname@example.org
Daniel is a specialist registrar in Cardiology and a PhD clinical research fellow in the group. He is conducting research into novel predictors of left ventricular reverse remodelling and risk in dilated cardiomyopathy.
Kat is a specialist registrar in Clinical Genetics and a Clinical Research Fellow in the Cardiovascular Genetics and Genomics group. She is interested in inherited cardiac conditions and plans to pursue a PhD to investigate the genetics of paediatric cardiomyopathy.
Melpi is a PhD student working on developing machine learning methods for patient stratification and survival prediction in cardiomyopathies. She is a using a combination of genomic and cardiac magnetic resonance (CMR) data to construct clinically informative machine and deep learning models, and identify important genetic and CMR features for cardiomyopathies.
Michael is a Postdoctoral Bioinformatician in the group. He is primarily analysing single cell transcriptomics data in order to identify shifts in transcriptional profiles associated with cardiomyopathy.
Namakau is based in the Royal Brompton Campus in the research delivery team, recruiting and collecting data from participants with cardiomyopathy - with a focus on dilated and hypertrophic cardiomyopathy
Nick is a PhD student working on bioinformatic methods for identifying novel-missense variants that are likely pathogenic by using information from paralogous genes. Additionally, he is also looking into specific variants associated with Hypertrophic cardiomyopathies (HCM) and is evaluating variant interpretation techniques for these variants using patient outcome data.
Francesco is a Honorary Research Fellow based at the University of Brescia (Italy), where he is a lecturer in medical genetics and a bioinformatician. His current research is mainly focused on understanding the genetic architecture of cardiomyopathies and psychiatric disorders through the analysis of cohorts and families, on developing algorithms that aid the identification of pathogenic variation and contribute to a refinement of current variant interpretation approaches.
Jemilat is a Band 6 Clinical Research Nurse within the Cardiovascular Genetics and Genomics Group at Imperial College. She supports the recruitment and informed consent of patients with Inherited Cardiac Conditions at the Royal Brompton and Harefield Hospitals. Current research she is working on aims to identify new interventions to treat and prevent inherited cardiomyopathies, focusing specifically on hypertrophic and dilated cardiomyopathies.
Catherine is a HEE/NIHR Pre-doctoral clinical academic fellow and Consultant Nurse in Paediatric Electrophysiology and Inherited Cardiovascular Conditions at Royal Brompton Hospital. Catherine’s research interest lies in the safety of exercise monitoring and prescription for children diagnosed with arrhythmias, particularly inherited arrhythmias.
Angharad is a Clinical Geneticist with a subspecialist interest in cardiac conditions; and a postdoctoral research fellow in the Cardiovascular Genetics and Genomics Group. She is interested in the diagnosis of complex cases, delineating and understanding the variability in clinical expression of recognised syndromes (expanding the phenotype) and identifying new syndromes and diagnoses to inform both clinical practice and research.
Dr. Paz Tayal is a Post doctoral Clinical Lecturer studying the imaging and genetics of cardiomyopathies. Upasana is working on integrating genetic, imaging, and multiparametric phenotyping data to explore gene-environmental interactions, improve risk stratification and identify predictors of remodelling in patients with dilated cardiomyopathy.
Pantazis Theotokis is a research assistant in bioinformatics interested in developing and implementing new pipelines for the analysis of NGS data in cardiomyopathies. He is currently working on ways to improve integration and harmonisation of genetic variants from various cohorts.
Elaine is the Go-DCM Study Project Manager
Sean is a Clinical Research PhD Fellow in the group. He is interested in the genomics of cardiomyopathy with a particular focus on evaluating the polygenic contribution of common genetic variation and identification of novel disease causing genes.